FDA Brief

Warning letters Drugs

FDA warning letter to

New Green Nutrition, Inc.

High riskIssued Oct 14, 2021Posted Oct 26, 2021Center for Drug Evaluation and Research | CDER

FDA warned New Green Nutrition that its diabetes products were unapproved new drugs and one contained prescription glyburide sold without a prescription.

What happened

In August 2021, FDA reviewed www.newgreenusa.com and linked Facebook and Twitter pages and found the company took orders for Xiao Ke Wan, Diabetee-Care, and Specific Jiang Tang Remedy. FDA said website, social media, and label claims about blood sugar and diabetes made the products drugs, but they lacked FDA approval and adequate directions for safe lay use. FDA also said Xiao Ke Wan's label lists glibenclamide (glyburide), a prescription blood sugar drug, and it was offered without a prescription.

What FDA found

  1. FDA said the products are drugs because website and label claims say they treat or affect blood sugar and diabetes.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)
  2. FDA said the products are unapproved new drugs because no FDA-approved applications are in effect for them.

    FD&C Act sections 505(a), 301(d), 21 U.S.C. 355(a), 331(d)
  3. FDA said the products are misbranded because their labeling lacks adequate directions for safe use by a layperson.

    FD&C Act section 502(f)(1), 21 U.S.C. 352(f)(1); 21 CFR 201.5
  4. FDA said Xiao Ke Wan's label lists glibenclamide (glyburide), a prescription blood sugar drug, and the product was offered without a prescription.

    FD&C Act section 503(b)(1), 301(k), 21 U.S.C. 353(b)(1), 331(k)

What FDA wants

FDA asks the company to notify it in writing within 15 working days of steps taken to correct the violations and prevent recurrence, with documentation, or explain why it cannot and when it will.

Who should pay attention

  • retailers and online marketplaces that sell herbal diabetes products
  • distributors and brands that buy supplements from New Green Nutrition
  • consumers using unapproved blood sugar products

This is a summary. Read the original letter on fda.gov.

New Green Nutrition, Inc.'s FDA history

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk

Full company page

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk